Monitoring

Patients prescribed anti-hypotensive medication must be followed on a regular basis, typically every 3 to 6 months. At follow-up visits, measurements of supine and standing blood pressures should be performed. In patients with supine hypertension, 24-hour ambulatory monitoring may be required to assess the severity of hypertension and the need for treatment. Yearly measurements of creatinine should be performed to monitor renal function and the potential development of renal failure.

The possibility of infection (most frequently urinary tract infection), dehydration, or the addition of a medication should be excluded in patients with known OH who experience a sudden worsening of symptoms.

Use of this content is subject to our disclaimer